Functional Genomic Influences on Disease Progression and Outcome in Sepsis
NCT00131196 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2016-05-16
Summary
The proposal is aimed at identifying genetic factors that determine the incidence and severity of, and the outcome from life-threatening infections (severe sepsis/septic shock) in patients admitted to High Dependency Units (HDUs) or Intensive Care Units (ICUs) with pneumonia which developed outside the hospital (community acquired pneumonia - CAP) or contamination of the abdominal cavity with faeces due to a leak in the bowel (faecal peritonitis). This will require the acquisition of a large, high quality resource of genetic material (DNA), plasma, urine, white blood cells and clinical information from well characterized groups of similar patients with, or at risk for, severe sepsis/septic shock. The principal objective is to perform studies which are sufficiently large to establish beyond doubt the influence of a series of selected "candidate" genes on the development, progress and outcome of sepsis.
Conditions
- Pneumonia
- Peritonitis
Sponsors & Collaborators
-
Sainsbury Family Charitable Trusts
collaborator OTHER -
Wellcome Trust
collaborator OTHER -
Queen Mary University of London
collaborator OTHER -
Barts and the London School of Medicine and Dentistry
collaborator OTHER -
University of Oxford
lead OTHER
Principal Investigators
-
Achyut Guleri, MD · Blackpool Victoria Hospital
-
Shond Laha, MD · Royal Preston Hospital
-
Christopher S Garrard, MD PhD · University of Oxford, UK
-
Charles J Hinds, MD · Queen Mary College, University of London, UK
-
Simon Baudouin, MD · Royal Victoria Infirmary and Freeman Hospital, Newcastle, UK
-
David Higgins, MD · Southend General Hospital, Southend, UK.
-
Richard Venn, MD · Worthing and Southlands Hospitals NHS Trust, Worthing, UK.
-
David Watson, MD · Homerton University Hospital, London, UK.
-
Atul Kapila, MD · Royal Berkshire Hospital, Reading, UK.
-
Simon Fletcher, MD · Norfolk and Norwich University Hospitals, Norwich, UK.
-
Andrew Johnston, MD · Addenbrooke's Hospital, Cambridge, UK.
-
Julian Bion, Professor · Queen Elizabeth Hospital, Birmingham, UK.
-
Gary Mills, MD · Royal Halamshire Hospital, Sheffield, UK.
-
Stephen Bonner, MD · James Cook University Hospital, Middlesborough, UK.
-
Mark Garfield, MD · The Ipswich Hospital, Ipswich, UK.
-
Ronald Baillie, MD · Antrim Hospital, Antrim, Northern Ireland.
-
George Findlay, MD · University Hospital of Wales, Cardiff,UK.
-
Geoffrey Bellingan, MD · UCLH Middlesex Hospital, London, UK.
-
Tony Gordon, MD · Charing Cross Hospital, London, UK.
-
Michelle Hayes, MD · Chelsea and Westminster Hospital, London, UK.
-
Dilshan Arawwawala, MD · Broomfield Hospital, Chelmsford, UK.
-
Andrew Bentley, MD · Wythenshawe Hospital, Manchester, UK.
-
Gareth Thomas, MD · Hope Hospital, Manchester, UK.
-
Julian Knight, MD · Wellcome Trust
-
Jonathan Thompson, MD · University Hospitals, Leicester
-
Jasmeet Soar, MD · Frenchay Hospital and Southmead Hospital, Bristol
-
Phil Watt, MD · Kettering General Hospital
-
Anton Krige, MD · Royal Blackburn Hospital
-
Ian Smith, MD · Castle Hill Hospital and Hull Royal Infirmary
-
Stephen Brett, MD · Hammersmith Hospitals NHS Trust
-
Jeronimo Moreno Cuesta, MD · North Middlesex University Hospital
-
Pyda Venkatesh, MD · Coventry University Hospital
-
Peter Hall, MD · Huddersfield Royal Infirmary and Calderdale Royal Hospital
-
Martin Kuper, MD · The WhittingtonHospital, London. UK
-
Sia Pesian, MD · Manor Hospital, Walsall. UK
-
Andrew Timmins, MD · Colchester Hospital, Colchester . UK
-
Stephen Drage, MD · Royal Sussex County Hospital
-
Martin Stotz, MD · St. Mary's Hospital, London, UK
-
Mark Blunt, MD · Queen Elizabeth Hospital, King's Lynn. UK
-
Nigel Webster, Professor · Aberdeen Royal Infirmary
-
Jane Minton, MD · St James Hospital, Leeds. UK
-
Matt Oram, MD · Cheltenham General Hospital, Cheltenham. UK
-
Ingrid Krupe, MD · Lewisham Hospital
-
Abhiram Mallick, MD · Leeds General Infirmary, Leeds. UK
-
Samuel Pambakian, MD · Frimley Park Hospital, Frimley. UK
-
Malcolm Watters, MD · Great Western Hospital, Swindon. UK
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-09-30
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Molecular Biomarkers for Sepsis
NCT04280354 ·Status: TERMINATED
-
Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in Sepsis
NCT06287684 ·Status: RECRUITING
-
Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit
NCT01085994 ·Status: UNKNOWN
-
Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis
NCT06446947 ·Status: RECRUITING
-
Identification of Cardiovascular and Molecular Prognostic Factors for the Mid- and Long-term Outcome of Sepsis
NCT03620409 ·Status: COMPLETED
-
Early Prediction of Sepsis by Using Metabolomics
NCT03996759 ·Status: UNKNOWN
-
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
NCT05052203 ·Status: UNKNOWN
-
Characterisation of Endothelial Cells in Different Inflammatory Pathologies
NCT06613256 ·Status: RECRUITING
-
Validation of Molecular and Protein Biomarkers in Sepsis
NCT04289506 ·Status: UNKNOWN
-
Next-Generation Sequencing Diagnostics of Bacteremia in Sepsis
NCT03356249 ·Status: COMPLETED
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Causes and Factors Associated With Outcomes in Community-acquired Sepsis and Severe Sepsis in Northeast Thailand
NCT02217592 ·Status: COMPLETED
-
Using Biomarkers to Optimize Antibiotic Strategies in Sepsis
NCT02207114 ·Status: COMPLETED ·Phase: NA
-
Novel Sepsis Sub-phenotypes Based on Trajectories of Vital Signs
NCT05826223 ·Status: COMPLETED
-
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001 ·Status: ENROLLING_BY_INVITATION
-
Algorithm for Predicting the Unfavorable Course of Sepsis in Children
NCT05908162 ·Status: COMPLETED
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Alterations of Immunologic Mediators During Severe Sepsis
NCT00484146 ·Status: TERMINATED
-
Correlation Between PTP1B Expression and Organ Failure During Sepsis
NCT02295514 ·Status: COMPLETED ·Phase: NA
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis
NCT04576819 ·Status: COMPLETED
-
Derivation and Validation of a Prognostic Model for Septic Patients at Hospital Admission
NCT03601767 ·Status: UNKNOWN
-
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328 ·Status: UNKNOWN
-
Inflammatory Mediators in Early Sepsis
NCT02692118 ·Status: UNKNOWN
-
Regulation of Endocrine, Metabolic, Immune and Bioenergetic Responses in Sepsis
NCT00187824 ·Status: UNKNOWN